Henrik Stage has a strong and diverse background from senior executive positions within the Biotech - and Industrial Industries, where he has been responsible for strategic planning, business development, finance, operations and investor relations. Before appointed CEO for Santaris Pharma Henrik served as the company’s CFO. Henrik previously held senior executive positions at Carlsberg, FLS Industries, Hempel and Hardy International, in Denmark, USA, Canada and Vietnam. Henrik Stage has a background in finance and received his masters degree in finance at the Copenhagen Business School, Denmark. Henrik Stage has been with Santaris Pharma since 2004.